Navigation Links
Gene variation simulates cholesterol response to oestrogen

According to a new study shows that women with a specific gene variant have a dramatic increase in 'good' cholesterol when they take oestrogen.// Previous research suggests that hormone replacement therapy (HRT) might protect women from heart disease. Now doctors at Forest University have discovered a strong genetic influence in how a woman's cholesterol profile responds to HRT.

An analysis of over 300 women with heart problems who took HRT or placebo showed that those with a specific gene variant had dramatic increases in high density lipoprotein (HDL or 'good' cholesterol). The gene concerned is called the oestrogen receptor alpha and, in this study, 20 per cent of the women carried it. They had a two to three times greater increase in HDL compared to women who did not have this variant of the gene.

Having high HDL should decrease the risk of heart disease although it is not yet known whether the current findings will mean fewer heart attacks for these women. The study may explain why previous research has shown no particular benefit from HRT in women with established heart disease - such research focusses on all women, not just the subgroup with the gene variant. The dramatic increases in HRT in this group would be diluted by results from those women who don't respond so well.

More research is needed before genetic testing for oestrogen receptor alpha can be recommended for women considering HRT. But this study promises a way of detecting those women who can most benefit from hormone replacement.


'"/>




Page: 1

Related medicine news :

1. Lifestyle variation can cut diabetes hazard
2. Differing reactions to anti clotting drugs may be due to genetic variation.
3. A better way to measure cholesterol
4. Genetics and cholesterol levels
5. Frequent meals can reduce cholesterol
6. Lecithin lowers cholesterol absorption in body
7. Step Aerobics Increases good cholesterol
8. Women are at risk with raised cholesterol
9. Functional foods reduce cholesterol
10. Exercise has a undeniable effect on cholesterol
11. Discovering cholesterol-absorbing genes

Post Your Comments:
(Date:12/1/2009)...Medical Center in Oak Lawn, Ill. has become the st...e first for Chicago’s south and southwest su...squo;s plans today (December 1) by the Illinois He... Springfield, Ill. (Vocus) -- ...has become the state’s newest kidney transpl...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, The Future of Central Nervous System Disea...titive Benchmarking, Product Pipeline and Deals An...4/The-Future-of-Central-Nervous-System-Diseases-Th...Benchmarking-Product-Pipeline-and-Deals-Analysis.h...
(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Monoclonal Antibodies - Mar...roduct Pipeline and Deals Analysis ,, http://...onal-Antibodies---Market-Forecasts-to-2015-Competi...sis.html ,, Summary ,, The author has re...
(Date:12/1/2009)...USNewswire/ -- The Kerlan Jobe Orthopaedic Clinic,...ed to pay the United States $3 million to settle a... HealthSouth Corporation, the Justice Department a... allegations that HealthSouth paid kickbacks to Ke...tions to the Kerlan Jobe Foundation, loan forgiven...
(Date:12/1/2009)...wire-USNewswire/ -- A scientist who broadened the ...s we can control and relieve it -- has won the 201...ychology. ,, Ronald Melzack, psychology profess...selected for the award from among 24 nominations. ...but instead in their brain through a pathway that ...
Breaking Medicine News(10 mins):Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13
...and heart muscle cells from rabbits, by researcher... have provided// a potential molecular explanation...ricular tachyarrhythmias (VTs) that can cause the ...e cells of the heart through Na+ channels are pred...
...own to underlie a form of Parkinson's disease (PD)...nd branching of neurons//, researchers have found....in made by mutant forms of the gene called LRRK2 a...nnections among such neurons is an early feature o...
...es are the true influencers of the "ultra thin" tr...sic.com, Twiggy says thin actresses go on extreme ...ing disorders among fans. She wants to see more cu...ls are naturally long and gangly, while a lot of t...
...itals, nursing homes, Diagnostic centres will soon...mum standards specified by law –// according to a ...een finalised by the Health Ministry and is being ...e same parameters will apply to a hospital, be it ...
...roduction in mice with type 2 diabetes, demonstrat...iabetes, say Tulane University gene// therapy rese... in the Early Edition of the Proceedings of the Na...se of their ability to repair many tissues in the ...
...logy, Jadavpur University, Kolkata and Department ... Andhra Pradesh done a// study on Plumeria Acumina...to evaluate the anti-inflammatory activity of meth... Plumeria Acuminata belongs to the family of Apoc...
Other Medicine News:Health News:Parkinson's Mutation Stunts Neurons 2Health News:Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves 2
(Date:12/1/2009)... , MONTREAL and DUSSELDORF, Germany, D...ading manufacturer of specialized graphics solutio...bH is now shipping the Matrox Xenia(TM) Series di... and Mammography solutions using Fujifilm Synapse...in computer based radiography, offering the world,...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, HPLC ... ,, http://www.reportlinker.com/p0164366/HPLC-... ,, Over the years, Liquid Chromatography has e... pharmaceuticals, food and beverage, research and ...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Lati...Policy environment, market analysis, forecasts and...inker.com/p0165648/Latin-American-Pharmaceutical-M...alysis-forecasts-and-growth-opportunities.html ...
Breaking Medicine Technology:FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8Drinking Weight Depression Linked in Young Women 3A Study 57563 1Drinking Weight Depression Linked in Young Women 3A Study 57563 2Childhood Stroke More Common Than Thought 57559 1Childhood Stroke More Common Than Thought 57559 2Childhood Stroke More Common Than Thought 57559 3Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 1Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 2Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 3
... 2 Pharmaleads has obtained from the,French Medic...a single,ascending dose Phase I study with PL37, i... pain., Neuropathic pain is a major chronic pain ...ld,s population of up to 6%, according to the most..., herpes, diabetes,antiviral or antitumor chemothe...
...Dual Modes of Action and Synergy with Chemotherapy...TC Bulletin Board: ACCP) presented data this week ...by blocking lactadherin, Angiolix has both,an anti...erative effect on,tumors themselves. In preclinica...d a significant anti-cancer effect in vivo; this e...
Other Medicine Technology:Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
Classic Series Gel
...-transparent gel bed using small sliding baffles t...unit using a UV-transparent gel tray sealed with t... are offered for any color-coding your lab require...d. Gel tray is not included with the Mini-Gel unit...
...a V-2 includes all components necessary for castin...equiring a minimal amount of benchspace. The direc...f leads and cords on the bench and saves space. De...y can detect when the gel box cover is absent or r...
... very fast and clear separation of DNA restriction... user to cast, run, and perform Southern or Northe...: 1 x electrophoresis tank and cover, 1 x Gel Make...x MT-T02 (50 x 60 mm tray), 1 x MT-C01 (Analytical...
Medicine Products: